Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.15B |
| 2 |
Amazon
AMZN
|
+$618M |
| 3 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$554M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$437M |
| 5 |
Apple
AAPL
|
+$333M |
Top Sells
| 1 |
Visa
V
|
+$2.38B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.59B |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.32B |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$993M |
| 5 |
DuPont de Nemours
DD
|
+$761M |
Sector Composition
| 1 | Technology | 20.31% |
| 2 | Financials | 12.52% |
| 3 | Consumer Discretionary | 10.54% |
| 4 | Communication Services | 10.36% |
| 5 | Healthcare | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SYRS
2776
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $150K | ﹤0.01% |
1,374
-531
| -28% | -$58K |
|
2777
OptimizeRx
OPRX
$322M
| $149K | ﹤0.01% |
4,795
-1,868
| -28% | -$58K |
|
2778
Provident Financial
PROV
$103M
| $149K | ﹤0.01% |
9,474
+873
| +10% | +$13.7K |
|
2779
Quince Therapeutics
QNCX
$85.9M
| $149K | ﹤0.01% |
5,362
-1,836
| -26% | -$51K |
|
2780
Ryerson Holding
RYI
$723M
| $149K | ﹤0.01% |
10,984
-1,589
| -13% | -$21.6K |
|
|
AD
2781
Array Digital Infrastructure, Inc.
AD
$4.41B
| $149K | ﹤0.01% |
4,856
+4,118
| +558% | +$126K |
|
2782
Daily Journal
DJCO
$562M
| $148K | ﹤0.01% |
366
-243
| -40% | -$98.3K |
|
2783
Kezar Life Sciences
KZR
$28.9M
| $148K | ﹤0.01% |
2,831
-381
| -12% | -$19.9K |
|
2784
Veru
VERU
$50.5M
| $148K | ﹤0.01% |
1,715
-713
| -29% | -$61.5K |
|
|
CGC
2785
Canopy Growth
CGC
$427M
| $147K | ﹤0.01% |
602
-14,190
| -96% | -$3.47M |
|
2786
Trinity Industries
TRN
$2.28B
| $147K | ﹤0.01% |
5,541
+933
| +20% | +$24.8K |
|
2787
W&T Offshore
WTI
$257M
| $147K | ﹤0.01% |
67,534
+24,377
| +56% | +$53.1K |
|
2788
Aterian
ATER
$9.73M
| $146K | ﹤0.01% |
+708
| New | +$146K |
|
2789
Luxfer Holdings
LXFR
$356M
| $146K | ﹤0.01% |
8,879
-4,367
| -33% | -$71.8K |
|
2790
Ribbon Communications
RBBN
$676M
| $145K | ﹤0.01% |
22,003
-24,232
| -52% | -$160K |
|
|
BACK
2791
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
| $145K | ﹤0.01% |
+3,157
| New | +$145K |
|
2792
Standard BioTools
LAB
$493M
| $144K | ﹤0.01% |
23,885
-95,692
| -80% | -$577K |
|
2793
Vanguard Mid-Cap ETF
VO
$88B
| $144K | ﹤0.01% |
696
| – | – |
|
|
ACER
2794
DELISTED
Acer Therapeutics Inc. Common Stock (DE)
ACER
| $144K | ﹤0.01% |
55,057
-545
| -1% | -$1.43K |
|
2795
Lindblad Expeditions
LIND
$735M
| $143K | ﹤0.01% |
8,316
-29,668
| -78% | -$510K |
|
|
TGP
2796
DELISTED
Teekay LNG Partners L.P.
TGP
| $143K | ﹤0.01% |
12,460
-9,236
| -43% | -$106K |
|
2797
Astronics
ATRO
$1.41B
| $141K | ﹤0.01% |
10,700
-72
| -0.7% | -$949 |
|
|
HOOK
2798
DELISTED
HOOKIPA Pharma
HOOK
| $141K | ﹤0.01% |
1,268
-165
| -12% | -$18.3K |
|
|
LBC
2799
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $141K | ﹤0.01% |
14,392
+5,358
| +59% | +$52.5K |
|
|
AMJ
2800
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
| $140K | ﹤0.01% |
10,052
| – | – |
|